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Abstract
Multiple myeloma can occasionally manifest with joint disease. We report the case of an individual
with a progressive bilateral carpal syndrome and a symmetrical severe seronegative polyarthritis
and joint swelling. Investigations revealed an erosive seronegative inflammatory arthritis in
association with bilateral carpal tunnel syndrome, anaemia, hepatic impairment and nephrotic-range
proteinuria. Synovial fluid cytology demonstrated plasmablasts and multinucleated cells with
products of chondrolysis. The diagnosis of multiple myeloma (with secondary amyloidosis) was
made on serum protein electrophoresis and bone marrow biopsy.
The relationship between myeloma and joint disease is discussed, highlighted by the presence in
this case of all three pathogenic features associated with arthritis in myeloma patients- an erosive
arthritis, carpal tunnel syndrome and an invasive tumoural arthritis.
Background
Multiple myeloma is a malignant proliferation of plasma
cells producing a monoclonal paraprotein. Multiple mye-
loma can present in a range of ways, for example, hyper-
calcaemia, hyperviscosity, renal failure and bone pains/
fractures. We report an unusual presentation of multiple
myeloma in the form of symmetrical severe polyarthritis
and joint swelling.
Case presentation
A 55 year old lady referred to the rheumatology clinic with
a 3 month history of progressive disabling polyarthralgia
and joint swelling, a 5 kg weight loss and fatigue. The pre-
dominant joints affected were her knees, shoulders, wrists
and small hand joints; her hand function was so impaired
at the time of presentation that she was no longer able to
feed herself. She denied joint stiffness, thigh pain, a his-
tory of skin rash, gastrointestinal or genitourinary symp-
toms.
On examination she was pale and cachectic. She had gen-
eralised soft tissue swelling of her hands, with markedly
reduced wrist movements, but without synovitis. Tinel's
and Phalen's tests were strongly positive bilaterally con-
sistent with carpal tunnel syndrome. Moderate cool effu-
sions were present in both knees. No synovitis was present
elsewhere and the rest of her systemic examination was
normal.
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She had a normochromic anaemia with a borderline leu-
copaenia (Hb 65 g/l, MCV 80 fl, WCC 3.9 × 109/l, platelets
200 × 109/l) and a grossly raised ESR (>140 mm/hr). She
was hypercalcaemic (corrected calcium 3.15 mmol/l,
phosphate 1.82 mmol/l, alkaline phosphatase 102 U/l)
with deranged liver function (LDH 1085 U/l, AST 46 U/l,
normal bilirubin, albumin and globulin levels). Signifi-
cant renal disease was evident (urea 22 mmol/l, creatinine
407 µmol/l), +1 of blood and protein on urinalysis, a cre-
atinine clearance of 16 ml/min and nephrotic range pro-
teinuria (5.29 g/d). Hand radiographs showed wrist joint
space narrowing with juxta-articular erosions.
Left knee synovial fluid cytology revealed atypical cells
resembling plasmablasts and multinucleate cells, as well
as changes consistent with chondrolysis, figure 1. It was
felt this was due to malignant infiltration of cartilage, with
bone and cartilage degradation products present in the
fluid. Wrist aspiration was dry.
Subsequently, rheumatoid factor, ANA, ENA and ANCA
were all negative and a non-contrast CT scan of her thorax,
abdomen and pelvis did not identify any abnormalities of
the viscera or the skeleton.
A panhypogammaglobulinaemia was identified [IgG was
3.7 g/l (8–16), IgA and IgM were both 0.1 g/l (1.4–4, 0.5–
2)]. Electrophoresis identified a small paraprotein band
(2 g/l), and a large amount of free kappa light chains in
both the serum and the urine (8.8 mg/l). Haematological
advice was sought and bone marrow biopsies were under-
taken, demonstrating a heavy (>90%) infiltration by
plasma cells including atypical forms, with a marked
reduction in granulopoiesis and erythropoiesis. Amyloid
protein was also identified in the walls of blood vessels
within the trephine biopsy.
Thus a diagnosis of aggressive multiple myeloma was
made (stage IIIB) and the patient was treated with aggres-
sive VCADVCAD chemotherapy (vincristine, cyclophos-
phamide, adriamycin and dexamethasone).
Unfortunately, she died from pneumonia seven weeks
after presentation.
Discussion
We have described the initial presentation of an aggressive
multiple myeloma with an erosive seronegative polyar-
thritis due to direct myelomatous joint infiltration. On
review of the literature, a few case reports have described
articular presentations of the plasma cell dyscrasias-multi-
ple myeloma (MM) [1,2], monoclonal gammopathy of
uncertain significance (MGUS) [1,2] and Waldenström's
macroglobulinaemia [3].
Joint involvement in myeloma is typically an oligoarthri-
tis [1] or a polyarticular rheumatoid-like pattern, as seen
in this case. Though individuals with myeloma are at
greater risk of both septic arthritis and gouty arthritis [3],
other pathophysiological mechanisms have been postu-
lated to account for joint disease. Firstly, local synovial
precipitation of cryoprecipitable paraproteins [1,4] or
immunoglobulin crystals [4] may activate the inflamma-
tory response resulting in an erosive arthritis [2]. Sec-
ondly, a carpal tunnel syndrome may develop from
intrasynovial deposition of amyloid protein or immu-
noglobulins [5]. Finally, juxta-articular plasmacytic
lesions may infiltrate the synovium and synovial fluid
resulting in a 'tumoural arthritis'. This direct tumour inva-
sion of the joint has been identified in other primary hae-
matological malignancies [3,6-8], however it is an
extremely rare manifestation of the plasma cell dyscrasias,
having only previously been described in 2 individuals
with myeloma [3,8]. This case demonstrated all of these
three pathogenic features- an erosive arthritis, carpal tun-
nel syndrome and an invasive tumoural arthritis.
This case is also unique in that the synovial fluid analysis
yielded the ultimate diagnosis. In a case series of 9 indi-
viduals with a monoclonal gammopathy (MGUS or MM)
and arthritis, the majority [5] were diagnosed with the
plasma dyscrasia first, synchronous diagnoses were made
in 3, and arthritis was the presenting feature in only 1 case
[1]. There is no information on the prognosis of cases pre-
senting in this manner, but based on the presence of anae-
mia, hypercalcaemia, renal impairment, advanced lytic
bone lesions and high tissue M-component levels in this
case, a high myeloma tissue mass was present, related to a
poor prognosis [9].
Knee synovial fluid: plasmablast-like cell containing particles  of phagocytosed degenerate articular cartilage surrounded by  suspended degenerate cartilage (Jenner Giemsa, ×1000) Figure 1
Knee synovial fluid: plasmablast-like cell containing particles 
of phagocytosed degenerate articular cartilage surrounded by 
suspended degenerate cartilage (Jenner Giemsa, ×1000). 
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Conclusion
We report the case of a patient presenting with tumoural
arthritis and carpal tunnel syndrome from an aggressive
myeloma. This case stresses the importance of analysing
the synovial fluid of any patient with an atypical joint dis-
ease or a suspected plasma cell dyscrasia for cytology and
immunohistochemistry, micro-organisms, crystals, and
also for immunoglobulins and amyloid.
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